drugset / Trial / NCT03244228

A Two Part Study to Assess Safety, PK, PD, and Food Effect of Oral HTL0016878

NCT03244228 ↗

Phase 1 Completed 120 enrolled Nxera Pharma UK Limited Allergan · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Phase 1, first in human, two-part, single centre, placebo-controlled, single and multiple ascending dose trial in healthy younger and elderly adult subjects, with an open-label, randomised, crossover arms to assess the effect of food on bioavailability.

Timeline

Start
2017-08-25
Primary completion
2019-09-23
Completion
2019-09-23

Drugs

EvaluationDrugModalityDoseRoute
Subject NBI-1117568 Unknown — Oral

Indications

No indication recorded.